 Home > Active Ingredient News > Antitumor Therapy > Melanoma pathology experts talked about BRAF gene testing management and treatment decisions

Melanoma pathology experts talked about BRAF gene testing management and treatment decisions

 Last Update: 2022-12-30
 Source: Internet
 Author: User

Tags

intco medical

medical shop

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

*For medical professionals only

Melanoma is a highly malignant tumor that originates in melanocytes and can occur in different parts
of the skin, mucous membranes, eyes and so on.
Due to high heterogeneity, clinical manifestations vary and treatment outcomes are poor
.
The discovery of BRAF targets has brought breakthroughs in the treatment of malignant melanoma, especially dabrafenib combined with trametinib dual target therapy has brought better survival benefits
to melanoma patients.
The "Medical Community" specially invited Professor Liu Yeqiang from Shanghai Dermatology Hospital/Tongji University Affiliated Dermatology Hospital, Professor Teng Xiaodong from the First Affiliated Hospital of Zhejiang University School of Medicine, Professor Xing Xiaoming from the Affiliated Hospital of Qingdao University, and Professor Xu Ziguang from Henan Provincial People's Hospital to share
their clinical experience in melanoma BRAF detection.

-End-

*This article is only used to provide scientific information to medical professionals and does not represent the views of this platform

*The "medical community" strives to publish content professionally and reliably, but does not make any commitment to the accuracy of the content; Relevant parties are requested to check
separately when adopting or using it as a basis for decision-making.

↓↓↓ Click "Read Original" to learn more clinical skills

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Crocetin27876-94-4

CAS No.: 27876-94-4

$1-1.1/G FOB

Betulinic acid472-15-1

CAS No.: 472-15-1

$1-1.1/G FOB

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.